210 related articles for article (PubMed ID: 35038045)
1. The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis.
Azadvari M; Mirmosayyeb O; Hosseini M; Vaheb S; Razavi SZE
Neurol Sci; 2022 Jun; 43(6):3879-3892. PubMed ID: 35038045
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis-an update.
Zali A; Motavaf M; Safari S; Ebrahimi N; Ghajarzadeh M; Khoshnood RJ; Mirmosayyeb O
Neurol Sci; 2023 Jan; 44(1):67-82. PubMed ID: 36058956
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of multiple sclerosis (MS) in Oceania, a systematic review, and meta-analysis.
Moghadasi AN; Ebrahimi N; Haghparast E; Rastkar M; Mokhberdezfuli M; Ghajarzadeh M
Neurol Sci; 2024 Jan; 45(1):75-82. PubMed ID: 37682389
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis.
Mirmosayyeb O; Shaygannejad V; Bagherieh S; Hosseinabadi AM; Ghajarzadeh M
Neurol Sci; 2022 Jan; 43(1):233-241. PubMed ID: 34787755
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis.
Mirmosayyeb O; Barzegar M; Nehzat N; Shaygannejad V; Sahraian MA; Ghajarzadeh M
J Clin Neurosci; 2020 Sep; 79():33-38. PubMed ID: 33070914
[TBL] [Abstract][Full Text] [Related]
6. Fampridine for gait imbalance in patients with multiple sclerosis (MS): a systematic review and meta-analysis.
Ghorbanpour S; Rahimibarghani S; Rohani S; Rastkar M; Ghajarzadeh M
Neurol Sci; 2023 Sep; 44(9):3059-3069. PubMed ID: 37055710
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis.
Nasirzadeh A; Jahanshahi R; Ghajarzadeh M; Mohammadi A; Moghadasi AN
Int J Prev Med; 2023; 14():81. PubMed ID: 37854988
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis.
Guitynavard F; Mirmosayyeb O; Razavi ERV; Hosseini M; Hosseinabadi AM; Ghajarzadeh M; Azadvari M
Mult Scler Relat Disord; 2022 Feb; 58():103392. PubMed ID: 35216773
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis.
Mirmosayyeb O; Ebrahimi N; Shekarian A; Afshari-Safavi A; Shaygannejad V; Barzegar M; Bagherieh S
J Clin Neurosci; 2023 Feb; 108():84-94. PubMed ID: 36630841
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.
Moghadasi AN; Mirmosayyeb O; Barzegar M; Sahraian MA; Ghajarzadeh M
Neurol Sci; 2021 Aug; 42(8):3093-3099. PubMed ID: 34100130
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis.
Askari M; Mirmosayyeb O; Ghaffary EM; Ghoshouni H; Shaygannejad V; Ghajarzadeh M
Mult Scler Relat Disord; 2022 Mar; 59():103680. PubMed ID: 35176641
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis.
Yazdani A; Ebrahimi N; Mirmosayyeb O; Ghajarzadeh M
BMC Womens Health; 2023 Jul; 23(1):352. PubMed ID: 37403051
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Aquatic Therapy on Depression, Fatigue, and Balance in Patients with Multiple Sclerosis (MS): a Systematic Review and Meta-Analysis.
Naeimi N; Rastkar M; Shahraki A; Abdi M; Ghajarzadeh M
Maedica (Bucur); 2024 Mar; 19(1):86-93. PubMed ID: 38736922
[No Abstract] [Full Text] [Related]
14. Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis.
Ghajarzadeh M; Mohammadi A; Sahraian MA
Autoimmun Rev; 2020 Oct; 19(10):102650. PubMed ID: 32801049
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence of Migraine in Inflammatory Bowel Disease, a Systematic Review and Meta-Analysis.
Olfati H; Mirmosayyeb O; Hosseinabadi AM; Ghajarzadeh M
Int J Prev Med; 2023; 14():66. PubMed ID: 37351058
[TBL] [Abstract][Full Text] [Related]
16. Is Celiac Disease (CD) Prevalent in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis.
Olfati H; Ghoshouni H; Ebrahimi N; Mohammadi A; Ghajarzadeh M
Mult Scler Int; 2022; 2022():7091140. PubMed ID: 36536783
[TBL] [Abstract][Full Text] [Related]
17. Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis.
Azimi A; Hanaei S; Sahraian MA; Mohammadifar M; Ramagopalan SV; Ghajarzadeh M
BMC Neurol; 2019 Nov; 19(1):286. PubMed ID: 31727014
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Mirmosayyeb O; Shaygannejad V; Nehzat N; Mohammadi A; Ghajarzadeh M
Int J Prev Med; 2021; 12():14. PubMed ID: 34084311
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis.
Yazdani A; Mirmosayyeb O; Ghaffary EM; Hashemi MS; Ghajarzadeh M
Neurol Sci; 2022 Jul; 43(7):4085-4094. PubMed ID: 35381877
[TBL] [Abstract][Full Text] [Related]
20. Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
Mirmosayyeb O; Ebrahimi N; Barzegar M; Afshari-Safavi A; Bagherieh S; Shaygannejad V
PLoS One; 2022; 17(4):e0266492. PubMed ID: 35439251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
